Dr. Minocher Maneck Battiwalla, MD

Dr. Battiwalla practices at TriStar Centennial Medical Center in Nashville, Tennessee, part of HCA Healthcare.

Dr. Battiwalla's NPI, 1861497570, was assigned on June 17, 2005. Dr. Battiwalla graduated from Medical College and Hospital Kolkata in 1994. Dr. Battiwalla's Tennessee license number on file is 56812.

Dr. Battiwalla's primary practice is TriStar Centennial Medical Center, at 2300 Patterson Street, Nashville, TN 37203 in Davidson County. The practice phone is (615) 342-1000.

Dr. Battiwalla's primary practice is TriStar Centennial Medical Center in Nashville, Tennessee, part of HCA Healthcare. The medical group on file is TriStar Bone Marrow Transplant. Dmand AI also links Dr. Battiwalla to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Battiwalla practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Battiwalla's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Battiwalla is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Battiwalla's licenses on file in 4 states: Tennessee, Alabama, Maryland and New York.

Dmand AI lists insomnia, pulmonary embolism and tobacco use among the conditions Dr. Battiwalla treats.

CMS data shows 552 Medicare services from Dr. Battiwalla across 4 procedure codes in 2024, for 98 Medicare patients. Medicare paid $49,844 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 98 Medicare patients who saw Dr. Battiwalla in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high blood pressure, and 67% have high cholesterol. Their average risk score is 2.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Battiwalla's median patient age at 67, with 39% women.

In 2024, Dr. Battiwalla wrote 153 Medicare Part D claims for 29 patients. 79% of them were for generic drugs. CMS names the drug for 45 of them, across 2 drugs with 11 or more claims each, at $602 in total drug cost. In 2023, CMS named 94 claims across 4 drugs.

Dr. Battiwalla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 23 papers to Dr. Battiwalla, published from 2007 to 2019. 2013 was the busiest year, with 4. The most frequent topics are Transplantation, Homologous, Hematopoietic Stem Cell Transplantation and Hematologic Neoplasms. Dr. Battiwalla has published most often in Bone Marrow Transplant. Dr. Battiwalla's most frequent co-authors are Philip Louis McCarthy, MD, Prathima R. Anandi, MD and Priyanka A. Pophali, MD.

Dmand AI links Dr. Battiwalla to 10 clinical trials, 3 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders and Anemia, Refractory, with Excess of Blasts. National Heart, Lung, and Blood Institute (NHLBI) sponsors the most, 9.

CMS Open Payments shows 77 general payments to Dr. Battiwalla from 22 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 66% of the total. Janssen Pharmaceuticals, Inc paid the most, $12,662.

Dr. Battiwalla graduated from Medical College and Hospital Kolkata in 1994.

Dr. Battiwalla is in network with 20 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.